1H-MRS of hippocampus in patients after first manic episode

World Journal of Biological Psychiatry

Volumn 15, Issue 2, 2014, Pages 145-154

  Gigante, Alexandre Duarte ^a   Lafer, Beny ^a   Yatham, Lakshmi N ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bipolar disorder; Disease onset; First mania; Magnetic resonance spectroscopy; Mood disorders

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LITHIUM; MOOD STABILIZER; N ACETYLASPARTIC ACID; VALPROATE SEMISODIUM; ASPARTIC ACID; HYDROGEN; N-ACETYLASPARTATE;

ADOLESCENT; ADULT; ANATOMIC LANDMARK; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DSM-IV; FEMALE; HIPPOCAMPUS; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD; PROTON NUCLEAR MAGNETIC RESONANCE; SUBSTANCE ABUSE; SUICIDE ATTEMPT; YOUNG ADULT; ANALOGS AND DERIVATIVES; DEVICES; DIAGNOSTIC USE; METABOLISM; NERVE CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; PROSPECTIVE STUDY; TIME;

ADOLESCENT; ADULT; ASPARTIC ACID; BIPOLAR DISORDER; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; HIPPOCAMPUS; HUMANS; HYDROGEN; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURONS; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84893849096     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2013.819120     Document Type: Article

References (65)

1. al-Mousawi AH , Evans N , Ebmeier KP , Roeda D , Chaloner F , Ashcroft GW. 1996. Limbic dysfunction in schizophrenia and mania. A study using 18F-labelled fl uorodeoxyglucose and positron emission tomography. Br J Psychiatry 169(4) : 509-516.
2. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: APA.
3. Atmaca M , Yildirim H , Ozdemir H , Poyraz AK , Tezcan E , Ogur E. 2006. Hippocampal 1 H MRS in fi rst-episode bipolar I patients. Prog Neuropsychopharmacol Biol Psychiatry 30 : 1235-1239. (Pubitemid 44216058)
4. Atmaca M , Yildirim H. 2012. Altered Neurochemical Ingredient of Hippocampus in Patients with Bipolar Depression. Depress Res Treat. doi:10.1155/2012/485249.
5. Benes FM , Kwok EW , Vincent SL , Todtenkopf MS. 1998. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44(2) : 88-97. (Pubitemid 28305527)
6. Bertolino A , Callicott JH , Mattay VS , Weidenhammer KM , Rakow R , Egan MF. 2001. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 49(1) : 39-46. (Pubitemid 32332952)
7. Bertolino A , Frye M , Callicott JH , Mattay VS , Rakow R , Shelton-Repella J , et al. 2003. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 53 : 906-913. (Pubitemid 36556176)
8. Brambilla P , Stanley JA , Nicoletti MA , Sassi RB , Mallinger AG , Frank E , et al. 2005. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 86(1) : 61-67. (Pubitemid 40487960)
9. Chang K , Adleman N , Dienes K , Barnea-Goraly N , Reiss A , Ketter T. 2003. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 53(11) : 1059-1065. (Pubitemid 36645236)
10. Colla M , Schubert F , Bubner M , Heidenreich J , Bajbouj M , Seifert F , et al. 2009. Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol. Mol Psychiatry 14(7) : 696-704.
11. Curtis VA , Dixon TA , Morris RG , Bullmore ET , Brammer MJ , Williams SC , et al. 2001. Differential frontal activation in schizophrenia and bipolar illness during verbal fl uency. J Affect Disord 66(2-3) : 111-121. (Pubitemid 32907516)
12. Daban C , Vieta E , Mackin P , Young A. 2005. Hypothalamic-pituitary- adrenal axis and bipolar disorder. Psychiatr Clin North Am 28(2) : 469-480.
13. Davanzo P , Yue K , Thomas M , Belin T , Mintz J , Venkatraman T , et al. 2003. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry 160(8) : 1442-1452. (Pubitemid 41070920)
14. Deicken RF , Pegues MP , Anzalone S , Feiwell R , Soher B. 2003. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 160 : 873-882. (Pubitemid 41079571)
15. DelBello MP , Cecil KM , Adler CM , Daniels JP , Strakowski SM. 2006. Neurochemical effects of olanzapine in fi rst-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology 31(6) : 1264-1273. (Pubitemid 43971842)
16. Forester BP , Finn CT , Berlow YA , Wardrop M , Renshaw PF , Moore CM. 2008. Brain lithium, N-acetyl aspartate and myoinositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Bipolar Disord 10(6) : 691-700.
17. Frye MA , Watzl J , Banakar S , O ' Neill J , Mintz J , Davanzo P , et al. 2007. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 32(12) : 2490-2499. (Pubitemid 350126840)
18. Gigante AD , Young LT , Yatham LN , Andreazza AC , Nery FG , Grinberg LT , et al. 2011. Morphometric postmortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 14(8) : 1075-1089.
19. Gigante AD , Bond DJ , Lafer B , Lam RW , Young LT , Yatham LN. 2012. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 14(5) : 478-487.
20. Guy W. 1976. Clinical Global Impressions. In: Guy W , editor. ECDEU assessment manual for psychopharmacology. Revised. Rockville, MD: National Institute of Mental Health.
21. Hallahan B , Newell J , Soares JC , Brambilla P , Strakowski SM , Fleck DE , et al. 2011. Structural magnetic resonance imaging in bipolar disorder: an international collaborative megaanalysis of individual adult patient data. Biol Psychiatry 69 : 326-335.
22. Hamakawa H , Kato T , Murashita J , Kato N. 1998. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 248(1) : 53-58. (Pubitemid 28130296)
23. Iosifescu DV , Moore CM , Deckersbach T , Tilley CA , Ostacher MJ , Sachs GS , et al. 2009. Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study. CNS Neurosci Ther 15 : 309-319.
24. Kapczinski F , Frey BN , Kauer-Sant ' Anna M , Grassi-Oliveira R. 2008. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 8(7) : 1101-1113. (Pubitemid 351962077)
25. Kapczinski F , Dal-Pizzol F , Teixeira AL , Magalhaes PV , Kauer-Sant ' Anna M , Klamt F , et al. 2010. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 15(8) : 784-786.
26. Kato T , Hamakawa H , Shioiri T , Murashita J , Takahashi Y , Takahashi S , et al. 1996. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 21(4) : 248-254. (Pubitemid 126737065)
27. Kauer-Sant ' Anna M , Kapczinski F , Andreazza AC , Bond DJ , Lam RW , Young LT , et al. 2009. Brain-derived neurotrophic factor and infl ammatory markers in patients with early-vs. latestage bipolar disorder. Int J Neuropsychopharmacol 12(4) : 447-458.
28. Kay SR , Fiszbein A , Opler LA. 1987. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13 : 261-276. (Pubitemid 18039085)
29. Ketter T A, Kimbrell TA , George MS , Dunn RT , Speer AM , Benson BE , et al. 2001. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 49(2) : 97-109. (Pubitemid 32119503)
30. Kim YK , Jung HG , Myint AM , Kim H , Park SH. 2007. Imbalance between pro-infl ammatory and anti-infl ammatory cytokines in bipolar disorder. J Affect Disord 104(1-3) : 91-95. (Pubitemid 350064526)
31. Kreis R. 2004. Issues of spectral quality in clinical 1 H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 17 : 361-381. (Pubitemid 39335175)
32. Kunz M , Gama CS , Andreazza AC , Salvador M , Ceres é r KM , Gomes FA , et al. 2008. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32(7) : 1677-1681.
33. Lafer , B , Renshaw PF , Sachs G , Christensen JD , Yurgelun-Todd D , Stoll AL , et al. 1994. Proton MRS of the basal ganglia in bipolar disorder. Biol Psychiatry 35 : 685.
34. Lagopoulos J , Malhi GS. 2007. A functional magnetic resonance imaging study of emotional Stroop in euthymic bipolar disorder . Neuroreport 18 : 1583-1587. (Pubitemid 47476388)
35. Liu L , Schulz SC , Lee S , Reutiman TJ , Fatemi SH. 2007. Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell Mol Neurobiol 27 : 351-358. (Pubitemid 46763882)
36. Lyoo K , Renshaw PF. 2010. Functional magnetic resonance imaging, diffusion tensor imaging, and magnetic resonance spectroscopy in bipolar disorder. In : Yatham LN, Maj M , editors. Bipolar disorder-clinical and neurobiological foundations. Oxford: Wiley-Blackwell. p. 133-199.
37. Machado-Vieira R , Andreazza AC , Viale CI , Zanatto V , Cereser V Jr, da Silva Vargas R , et al. 2007. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421 : 33-36. (Pubitemid 46908861)
38. Malhi GS , Lagopoulos J , Owen AM , Ivanovski B , Shnier R , Sachdev P. 2007a. Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord 97 : 109-122. (Pubitemid 44937425)
39. Malhi GS , Ivanovski B , Wen W , Lagopoulos J , Moss K , Sachdev P. 2007b. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania. Acta Psychiatr Scand Suppl 434 : 57-66. (Pubitemid 47231069)
40. Moghaddam B. 1993. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 60(5) : 1650-1657. (Pubitemid 23127567)
41. Moore CM , Breeze JL , Gruber SA , Babb SM , Frederick BB , Villafuerte RA , et al. 2000. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2(3 Pt 2) : 207-216.
42. Moore GJ , Bebchuk JM , Parrish JK , Faulk MW , Arfken CL , Strahl-Bevacqua J , et al. 1999. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 156 : 1902-1908.
43. Moore GJ , Bebchuk JM , Hasanat K , Chen G , Seraji-Bozorgzad N , Wilds IB. 2000. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2 ' s neurotrophic effects? Biol Psychiatry 48(1) : 1-8. (Pubitemid 30407144)
44. Nery FG , Stanley JA , Chen HH , Hatch JP , Nicoletti MA , Monkul ES. 2010. Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study. J Psychiatr Res 44(5) : 278-285.
45. Ng WX , Lau IY , Graham S , Sim K. 2009. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Neurosci Biobehav Rev 33 : 336-354.
46. Olvera RL , Caetano SC , Fonseca M , Nicoletti M , Stanley JA , Chen HH. 2007. Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J Child Adolesc Psychopharmacol 17(4) : 461-473. (Pubitemid 47417774)
47. Overall JE , Gorham DR. 1962. The Brief Psychiatric Rating Scale. Psychol Rep 10 : 799-812.
48. Patel NC , DelBello MP , Cecil KM , Stanford KE , Adler CM , Strakowski SM. 2008. Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium. J Child Adolesc Psychopharmacol 18(2) : 132-139. (Pubitemid 351591441)
49. Pavuluri MN , O ' Connor MM , Harral E , Sweeney JA. 2007. Affective neural circuitry during facial emotion processing in pediatric bipolar disorder. Biol Psychiatry 62 : 158-167. (Pubitemid 46963246)
50. Provencher SW. 1993. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 : 672-679. (Pubitemid 23360802)
51. Rao JS , Harry GJ , Rapoport SI , Kim HW. 2010. Increased excitotoxicity and neuroinfl ammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15(4) : 384-392.
52. Scherk H , Backens M , Schneider-Axmann T , Kemmer C , Usher J , Reith W , et al. 2008. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder. Acta Psychiatr Scand 117 : 283-288. (Pubitemid 351347464)
53. Schmider J , Lammers CH , Gotthardt U , Dettling M , Holsboer F , Heuser IJ. 1995. Combined dexamethasone/corticotropinreleasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol Psychiatry 38(12) : 797-802. (Pubitemid 3020006)
54. Schubert MI , Kalisch R , Sotiropoulos I , Catania C , Sousa N , Almeida OF , et al. 2008. Effects of altered corticosteroid milieu on rat hippocampal neurochemistry and structure-an in vivo magnetic resonance spectroscopy and imaging study. J Psychiatr Res 42(11) : 902-912.
55. Senaratne R , Milne A , MacQueen G , Hall G. 2009. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res 172 : 205-209.
56. Sheehan DV , Lecrubier Y , Sheehan KH , Amorim P , Janavs J , Weiller E , et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20) : 22-33. (Pubitemid 29001829)
57. Silverstone PH , Wu RH , O ' Donnell T , Ulrich M , Asghar SJ , Hanstock CC. 2003. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol (2) : 73-79. (Pubitemid 36343975)
58. Soares JC , Mann JJ. 1997. The anatomy of mood disorders-review of structural neuroimaging studies. Biol Psychiatry 41(1) : 86-106. (Pubitemid 27050649)
59. Strakowski SM , DelBello MP , Adler CM. 2005. The functional neuroanatomy of bipolar disorder. A review of neuroimaging fi ndings. Mol Psychiatry 10 : 105-116. (Pubitemid 40139591)
60. Strakowski SM , Adler CM , Almeida J , Altshuler LL , Blumberg HP , Chang KD , et al. 2012. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord 14(4) : 313-325.
61. Watson S , Gallagher P , Ritchie JC , Ferrier IN , Young AH. 2004. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 184 : 496-502. (Pubitemid 38725709)
62. Williams JBW , Link MJ , Rosenthal NE , Terman M. 1988. Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGHSAD) . New York: New York State Psychiatric Institute.
63. Yatham LN , Kauer-Sant ' Anna M , Bond DJ , Lam RW , Torres I. 2009. Course and outcome after the fi rst manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project. Can J Psychiatry 54(2) : 105-112.
64. Young RC , Biggs JT , Ziegler VE , Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 : 429-435. (Pubitemid 9006756)
65. Zarate CJ , Singh J , Manji H. 2006. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59 : 1006-1020. (Pubitemid 43849653)